| Available-for-Sale Securities, at Fair Value |
Available-for-Sale Securities, at Fair Value The Company holds both Agency and non-Agency available-for sale, or AFS, investment securities which are carried at fair value on the consolidated balance sheets. The following table presents the Company’s AFS investment securities by collateral type as of December 31, 2022 and December 31, 2021:
|
|
|
|
|
|
|
|
|
|
|
|
| (in thousands) |
December 31,
2022 |
|
December 31,
2021 |
| Agency: |
|
|
|
| Federal National Mortgage Association |
$ |
4,112,556 |
|
|
$ |
5,040,988 |
|
| Federal Home Loan Mortgage Corporation |
3,332,314 |
|
|
1,922,809 |
|
| Government National Mortgage Association |
208,706 |
|
|
185,602 |
|
| Non-Agency |
125,158 |
|
|
12,304 |
|
| Total available-for-sale securities |
$ |
7,778,734 |
|
|
$ |
7,161,703 |
|
At December 31, 2022 and December 31, 2021, the Company pledged AFS securities with a carrying value of $7.4 billion and $7.0 billion, respectively, as collateral for repurchase agreements. See Note 11 - Repurchase Agreements.
At December 31, 2022 and December 31, 2021, the Company did not have any securities purchased from and financed with the same counterparty that did not meet the conditions of ASC 860, Transfers and Servicing, to be considered linked transactions and, therefore, classified as derivatives.
The Company is not required to consolidate VIEs for which it has concluded it does not have both the power to direct the activities of the VIEs that most significantly impact the entities’ performance, and the obligation to absorb losses or the right to receive benefits of the entities that could be significant. The Company’s investments in these unconsolidated VIEs include all non-Agency securities, which are classified within available-for-sale securities, at fair value on the consolidated balance sheets. As of December 31, 2022 and December 31, 2021, the carrying value, which also represents the maximum exposure to loss, of all non-Agency securities in unconsolidated VIEs was $125.2 million and $12.3 million, respectively.
The following tables present the amortized cost and carrying value of AFS securities by collateral type as of December 31, 2022 and December 31, 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
| (in thousands) |
Principal/ Current Face |
|
Un-amortized Premium |
|
Accretable Purchase Discount |
|
|
|
Amortized Cost |
|
Allowance for Credit Losses |
|
Unrealized Gain |
|
Unrealized Loss |
|
Carrying Value |
Agency: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal and interest |
$ |
7,781,277 |
|
|
$ |
189,246 |
|
|
$ |
(33,413) |
|
|
|
|
$ |
7,937,110 |
|
|
$ |
— |
|
|
$ |
6,310 |
|
|
$ |
(325,960) |
|
|
$ |
7,617,460 |
|
| Interest-only |
963,866 |
|
|
45,882 |
|
|
— |
|
|
|
|
45,882 |
|
|
(6,785) |
|
|
1,890 |
|
|
(4,871) |
|
|
36,116 |
|
| Total Agency |
8,745,143 |
|
|
235,128 |
|
|
(33,413) |
|
|
|
|
7,982,992 |
|
|
(6,785) |
|
|
8,200 |
|
|
(330,831) |
|
|
7,653,576 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Agency |
1,263,789 |
|
|
8,511 |
|
|
(225) |
|
|
|
|
131,635 |
|
|
(173) |
|
|
545 |
|
|
(6,849) |
|
|
125,158 |
|
| Total |
$ |
10,008,932 |
|
|
$ |
243,639 |
|
|
$ |
(33,638) |
|
|
|
|
$ |
8,114,627 |
|
|
$ |
(6,958) |
|
|
$ |
8,745 |
|
|
$ |
(337,680) |
|
|
$ |
7,778,734 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
| (in thousands) |
Principal/ Current Face |
|
Un-amortized Premium |
|
Accretable Purchase Discount |
|
|
|
Amortized Cost |
|
Allowance for Credit Losses |
|
Unrealized Gain |
|
Unrealized Loss |
|
Carrying Value |
Agency: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal and interest |
$ |
6,411,363 |
|
|
$ |
270,699 |
|
|
$ |
(12) |
|
|
|
|
$ |
6,682,050 |
|
|
$ |
— |
|
|
$ |
171,308 |
|
|
$ |
(4,855) |
|
|
$ |
6,848,503 |
|
| Interest-only |
3,198,447 |
|
|
305,577 |
|
|
— |
|
|
|
|
305,577 |
|
|
(12,851) |
|
|
20,699 |
|
|
(12,529) |
|
|
300,896 |
|
| Total Agency |
9,609,810 |
|
|
576,276 |
|
|
(12) |
|
|
|
|
6,987,627 |
|
|
(12,851) |
|
|
192,007 |
|
|
(17,384) |
|
|
7,149,399 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Agency |
1,940,815 |
|
|
16,533 |
|
|
(27) |
|
|
|
|
17,386 |
|
|
(1,387) |
|
|
33 |
|
|
(3,728) |
|
|
12,304 |
|
| Total |
$ |
11,550,625 |
|
|
$ |
592,809 |
|
|
$ |
(39) |
|
|
|
|
$ |
7,005,013 |
|
|
$ |
(14,238) |
|
|
$ |
192,040 |
|
|
$ |
(21,112) |
|
|
$ |
7,161,703 |
|
The following table presents the Company’s AFS securities according to their estimated weighted average life classifications as of December 31, 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
| (in thousands) |
Agency |
|
Non-Agency |
|
Total |
| < 1 year |
$ |
2,001 |
|
|
$ |
— |
|
|
$ |
2,001 |
|
| ≥ 1 and < 3 years |
28,953 |
|
|
— |
|
|
28,953 |
|
| ≥ 3 and < 5 years |
149,872 |
|
|
117,203 |
|
|
267,075 |
|
| ≥ 5 and < 10 years |
7,471,903 |
|
|
7,955 |
|
|
7,479,858 |
|
| ≥ 10 years |
847 |
|
|
— |
|
|
847 |
|
| Total |
$ |
7,653,576 |
|
|
$ |
125,158 |
|
|
$ |
7,778,734 |
|
Measurement of Allowances for Credit Losses on AFS Securities
The Company uses a discounted cash flow method to estimate and recognize an allowance for credit losses on both Agency and non-Agency AFS securities that are not accounted for under the fair value option. The following tables present the changes for the years ended December 31, 2022, 2021 and 2020 in the allowance for credit losses on Agency and non-Agency AFS securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
December 31, 2022 |
|
|
| (in thousands) |
Agency |
|
Non-Agency |
|
Total |
Allowance for credit losses at beginning of period |
$ |
(12,851) |
|
|
$ |
(1,387) |
|
|
$ |
(14,238) |
|
|
|
|
|
|
|
Additions on securities for which credit losses were not previously recorded |
(482) |
|
|
(501) |
|
|
(983) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Increase) decrease on securities with previously recorded credit losses |
(3,462) |
|
|
1,715 |
|
|
(1,747) |
|
Write-offs |
10,010 |
|
|
— |
|
|
10,010 |
|
|
|
|
|
|
|
Allowance for credit losses at end of period |
$ |
(6,785) |
|
|
$ |
(173) |
|
|
$ |
(6,958) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
December 31, 2021 |
| (in thousands) |
Agency |
|
Non-Agency |
|
Total |
Allowance for credit losses at beginning of period |
$ |
(17,889) |
|
|
$ |
(4,639) |
|
|
$ |
(22,528) |
|
|
|
|
|
|
|
Additions on securities for which credit losses were not previously recorded |
(190) |
|
|
(4,365) |
|
|
(4,555) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase on securities with previously recorded credit losses |
(4,542) |
|
|
(666) |
|
|
(5,208) |
|
Write-offs |
9,770 |
|
|
8,283 |
|
|
18,053 |
|
|
|
|
|
|
|
Allowance for credit losses at end of period |
$ |
(12,851) |
|
|
$ |
(1,387) |
|
|
$ |
(14,238) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
December 31, 2020 |
| (in thousands) |
Agency |
|
Non-Agency |
|
Total |
Allowance for credit losses at beginning of period |
$ |
— |
|
|
$ |
(244,876) |
|
|
$ |
(244,876) |
|
|
|
|
|
|
|
Additions on securities for which credit losses were not previously recorded |
(32,931) |
|
|
(11,428) |
|
|
(44,359) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Reductions for securities sold |
— |
|
|
246,792 |
|
|
246,792 |
|
|
|
|
|
|
|
| Decrease (increase) on securities with previously recorded credit losses |
385 |
|
|
(14,466) |
|
|
(14,081) |
|
Write-offs |
14,657 |
|
|
21,874 |
|
|
36,531 |
|
Recoveries of amounts previously written off |
— |
|
|
(2,535) |
|
|
(2,535) |
|
Allowance for credit losses at end of period |
$ |
(17,889) |
|
|
$ |
(4,639) |
|
|
$ |
(22,528) |
|
Prior to the adoption of ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments on January 1, 2020, the Company periodically evaluated AFS securities for other-than-temporary impairments, or OTTI, and recognized the related credit losses in earnings. As of December 31, 2019, the Company’s cumulative credit losses related to OTTI totaled $17.0 million. During the three months ended March 31, 2020, the Company sold all securities for which OTTI had been recognized prior to January 1, 2020, reducing the Company’s cumulative credit losses related to OTTI to zero.
The following tables present the components comprising the carrying value of AFS securities for which an allowance for credit losses has not been recorded by length of time that the securities had an unrealized loss position as of December 31, 2022 and December 31, 2021. At December 31, 2022 and December 31, 2021, the Company held 704 and 756 AFS securities, respectively; of the securities for which an allowance for credit losses has not been recorded, 553 and 45 were in an unrealized loss position for less than twelve consecutive months. At both December 31, 2022 and December 31, 2021, none of the Company’s AFS securities were in an unrealized loss position for more than twelve months without an allowance for credit losses recorded.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
|
Unrealized Loss Position for |
|
Less than 12 Months |
|
12 Months or More |
|
Total |
| (in thousands) |
Estimated Fair Value |
|
Gross Unrealized Losses |
|
Estimated Fair Value |
|
Gross Unrealized Losses |
|
Estimated Fair Value |
|
Gross Unrealized Losses |
| Agency |
$ |
7,168,694 |
|
|
$ |
(328,258) |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
7,168,694 |
|
|
$ |
(328,258) |
|
| Non-Agency |
117,816 |
|
|
(5,933) |
|
|
— |
|
|
— |
|
|
117,816 |
|
|
(5,933) |
|
| Total |
$ |
7,286,510 |
|
|
$ |
(334,191) |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
7,286,510 |
|
|
$ |
(334,191) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
Unrealized Loss Position for |
|
Less than 12 Months |
|
12 Months or More |
|
Total |
| (in thousands) |
Estimated Fair Value |
|
Gross Unrealized Losses |
|
Estimated Fair Value |
|
Gross Unrealized Losses |
|
Estimated Fair Value |
|
Gross Unrealized Losses |
| Agency |
$ |
2,371,216 |
|
|
$ |
(12,031) |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
2,371,216 |
|
|
$ |
(12,031) |
|
| Non-Agency |
9,613 |
|
|
(1,230) |
|
|
— |
|
|
— |
|
|
9,613 |
|
|
(1,230) |
|
| Total |
$ |
2,380,829 |
|
|
$ |
(13,261) |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
2,380,829 |
|
|
$ |
(13,261) |
|
Realized Gains and Losses
Gains and losses from the sale of AFS securities are recorded as realized gains (losses) within (loss) gain on investment securities in the Company’s consolidated statements of comprehensive loss. The following table presents details around sales of AFS securities during the years ended December 31, 2022, 2021 and 2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
|
|
December 31, |
| (in thousands) |
|
|
|
|
2022 |
|
2021 |
|
2020 |
| Proceeds from sales of available-for-sale securities |
|
|
|
|
$ |
7,793,705 |
|
|
$ |
6,274,193 |
|
|
$ |
18,349,338 |
|
| Amortized cost of available-for-sale securities sold |
|
|
|
|
(8,359,967) |
|
|
(6,137,824) |
|
|
(19,273,667) |
|
| Total realized (losses) gains on sales, net |
|
|
|
|
$ |
(566,262) |
|
|
$ |
136,369 |
|
|
$ |
(924,329) |
|
|
|
|
|
|
|
|
|
|
|
| Gross realized gains |
|
|
|
|
$ |
40,574 |
|
|
$ |
167,269 |
|
|
$ |
337,360 |
|
| Gross realized losses |
|
|
|
|
(606,836) |
|
|
(30,900) |
|
|
(1,261,689) |
|
| Total realized (losses) gains on sales, net |
|
|
|
|
$ |
(566,262) |
|
|
$ |
136,369 |
|
|
$ |
(924,329) |
|
|